Anti-PD-L2 antibody [EPR25200-50] - BSA and Azide free
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal PD-L2 antibody. Carrier free. Suitable for IP, WB, IHC-P and reacts with Human samples.
View Alternative Names
CD273, B7DC, PDCD1L2, PDL2, PDCD1LG2, Programmed cell death 1 ligand 2, PD-1 ligand 2, PD-L2, PDCD1 ligand 2, Programmed death ligand 2, Butyrophilin B7-DC, B7-DC
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L2 antibody [EPR25200-50] - BSA and Azide free (AB288308)
This data was developed using ab288298, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human endometrial cancer tissue labelling PD-L2 with ab288298 at 1/1000 (0.546 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection) was used. Positive staining on human endometrial cancer (PMID : 27446374). The section was incubated with ab288298 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection) was used.
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L2 antibody [EPR25200-50] - BSA and Azide free (AB288308)
This data was developed using ab288298, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Panel A HDLM-2 Panel B Jurkat labelling PD-L2 with ab288298 at 1/1000 (0.546 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection) was used. Positive cell line HDLM-2 (Panel A) was positive and negative cell line Jurkat (Panel B) was negative.The section was incubated with ab288298 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L2 antibody [EPR25200-50] - BSA and Azide free (AB288308)
This data was developed using ab288298, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissue labelling PD-L2 with ab288298 at 1/1000 (0.546 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection) was used. Positive staining on human breast cancer. The section was incubated with ab288298 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L2 antibody [EPR25200-50] - BSA and Azide free (AB288308)
This data was developed using ab288298, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labelling PD-L2 with ab288298 at 1/1000 (0.546 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection) was used. Positive staining is found in the germinal centre of human tonsil. The section was incubated with ab288298 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
- IP
Supplier Data
Immunoprecipitation - Anti-PD-L2 antibody [EPR25200-50] - BSA and Azide free (AB288308)
This data was developed using ab288298, the same antibody clone in a different buffer formulation.
PD-L2 was immunoprecipitated from 0.35 mg HDLM-2 (human Hodgkin lymphoma) whole cell lysate with ab288298 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab288298 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : HDLM-2 (human Hodgkin lymphoma) whole cell lysate 10 ug
Lane 2 : ab288298 IP in HDLM-2 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab288298 in HDLM-2 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 92 seconds
All lanes:
Immunoprecipitation - Anti-PD-L2 antibody [EPR25200-50] (<a href='/en-us/products/primary-antibodies/pd-l2-antibody-epr25200-50-ab288298'>ab288298</a>)
Predicted band size: 31 kDa
Observed band size: 45-60 kDa
false
- WB
Lab
Western blot - Anti-PD-L2 antibody [EPR25200-50] - BSA and Azide free (AB288308)
This data was developed using ab288298, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Negative control : Jurkat (PMID : 27631416).
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes:
Western blot - Anti-PD-L2 antibody [EPR25200-50] (<a href='/en-us/products/primary-antibodies/pd-l2-antibody-epr25200-50-ab288298'>ab288298</a>) at 1/1000 dilution
Lane 1:
HDLM-2 (human Hodgkin lymphoma) whole cell lysate at 20 µg
Lane 2:
Jurkat (human T cell leukemia T lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 31 kDa
Observed band size: 45-60 kDa
false
Exposure time: 125s
Related conjugates and formulations (2)
-
Anti-PD-L2 antibody [EPR25200-50]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PD-L2 antibody [EPR25200-50]
Reactivity data
Product details
ab288308 is the carrier-free version of ab288298.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PD-L2 offers protection to tissues from autoimmunity by regulating T-cell activation and fostering tolerance. By engaging with its receptor PD-1 PD-L2 forms a complex that modulates the immune response to prevent overactivation. This interaction limits the immune system's potential damage to healthy tissues maintaining proper immune function in diverse environments.
Pathways
PD-L2 participates in the immune checkpoint pathways where it works closely with PD-1 to mediate immune responses. PD-L2 forms an important part of the program death-1 (PD-1) pathway which plays a prominent role in downregulating T-cell activity. It relates to proteins such as PD-L1 which also interacts with PD-1 modulating immune tolerance and response to infections or tumors.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com